Pharmaceuticals
- All
- News
- Videos
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Stock Market Highlights: Markets End In Green As Wall Street, Asian Peers Edge Higher
Sensex Today | Nifty 50 | Stock Market Highlights: GIFT Nifty indicated another positive start for Nifty50 and the Sensex.
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
Tomatoes, Carrots And Lettuce Absorb Low Levels Of Antidepressants From Wastewater Irrigation: Johns Hopkins Study
A new study finds crops irrigated with treated wastewater can absorb trace pharmaceuticals such as antidepressants and epilepsy medicines. Researchers found these compounds mainly accumulate in plant leaves rather than edible parts.
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Stock Market Highlights: Markets End In Green As Wall Street, Asian Peers Edge Higher
Sensex Today | Nifty 50 | Stock Market Highlights: GIFT Nifty indicated another positive start for Nifty50 and the Sensex.
-
The Lancet Reports A Boom In Fake Obesity Drugs: What You Need To Know
A new Lancet report pinpoints that a boom in counterfeit obesity drugs is taking place. Here is what you need to know about the dangers that these drugs pose and why following the properly established medical guidance is key to being safe.
-
Tomatoes, Carrots And Lettuce Absorb Low Levels Of Antidepressants From Wastewater Irrigation: Johns Hopkins Study
A new study finds crops irrigated with treated wastewater can absorb trace pharmaceuticals such as antidepressants and epilepsy medicines. Researchers found these compounds mainly accumulate in plant leaves rather than edible parts.
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
